Skip to main content
HAO
NASDAQ Trade & Services

Haoxi Health Seeks Shareholder Approval for Massive Capital Increase and Extreme Reverse Stock Split Authority

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
10
Price
$1.63
Mkt Cap
$107.284M
52W Low
$1.39
52W High
$295.68
Market data snapshot near publication time

summarizeSummary

Haoxi Health Technology is asking shareholders to approve an astronomical increase in authorized shares and authorization for an extreme reverse stock split, signaling severe financial distress and potential for massive dilution.


check_boxKey Events

  • Massive Authorized Share Capital Increase Proposed

    Shareholders will vote on increasing authorized share capital from approximately 9.38 million shares to over 859 billion shares (post-split equivalent), creating an immense potential for future dilution.

  • Extreme Reverse Stock Split Authority Sought

    The company is seeking authorization for the Board to implement one or more reverse stock splits at an aggregate cumulative ratio of up to 1-for-8,000, aimed at regaining Nasdaq listing compliance. This follows a 1:128 reverse split executed today.

  • Amendments to Memorandum and Articles of Association

    Proposals include adopting new M&AA to reflect the share capital increase and reverse split, and a change in quorum requirements for shareholder meetings.

  • Meeting Scheduled for June 2, 2026

    An Extraordinary General Meeting is scheduled for June 2, 2026, for shareholders to vote on these critical proposals.


auto_awesomeAnalysis

Haoxi Health Technology is seeking shareholder approval for a colossal increase in its authorized share capital, from approximately 9.38 million shares to over 859 billion shares (post-split equivalent). This authorization, if fully utilized, represents an extreme potential for dilution that could severely impact existing shareholder value. Concurrently, the company is requesting authority for the Board to implement further reverse stock splits at an aggregate cumulative ratio of up to 1-for-8,000, explicitly to maintain compliance with Nasdaq's minimum bid price rules. This comes on the same day a 1:128 reverse split was executed, indicating severe and ongoing stock price distress and a desperate attempt to avoid delisting. The combination of these proposals signals a company in profound financial difficulty, preparing for significant capital raises that could drastically dilute current ownership.

At the time of this filing, HAO was trading at $1.63 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $107.3M. The 52-week trading range was $1.39 to $295.68. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HAO - Latest Insights

HAO
May 21, 2026, 4:35 PM EDT
Filing Type: 6-K
Importance Score:
10
HAO
May 19, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
9
HAO
May 12, 2026, 6:35 PM EDT
Filing Type: 6-K
Importance Score:
9
HAO
May 12, 2026, 9:10 AM EDT
Filing Type: 424B5
Importance Score:
9
HAO
May 11, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
HAO
Apr 22, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
9
HAO
Mar 03, 2026, 7:39 AM EST
Source: Reuters
Importance Score:
7
HAO
Mar 03, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
HAO
Feb 10, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
9
HAO
Jan 23, 2026, 5:18 PM EST
Filing Type: 424B5
Importance Score:
10